Daniela Baglieri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniela Baglieri has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Fabrizio Cesaroni
University of Messina
2 shared publications - Alba Marino
University of Messina
1 shared publication - Alberto Di Minin
U. of California, Berkeley
1 shared publication - Andrea Piccaluga
Scuola Superiore Sant'Anna
1 shared publication David Carfì
Department of Mathematics, University of California Riverside, Riverside, California, USA
1 shared publication- Gianni Lorenzoni
Management Department, University of Bologna, Bologna, Italy
1 shared publication
Latest Publications
- 18 November 2024
- Published by Springer Nature in Asian Business & Management
- Vol. 23 (5) , 660-682
Turning green hydrogen into firms’ decarbonization strategies: opportunities, challenges, and implications for China
- 18 November 2024
- Published by Springer Nature in Asian Business & Management
- Vol. 23 (5) , 660-682
Turning green hydrogen into firms’ decarbonization strategies: opportunities, challenges, and implications for China
- 30 March 2022
- Published by Springer Nature
- p. 5-27
Disabilities and Accessible Tourism: Recent Development and Future Directions in Management Studies
- 30 March 2022
- Published by Springer Nature
- p. 5-27
Disabilities and Accessible Tourism: Recent Development and Future Directions in Management Studies
- 6 February 2016
- Published by Taylor & Francis in International Studies of Management & Organization
- Vol. 46 (2-3) , 179-201
Asymmetric R&D Alliances in the Biopharmaceutical Industry
In this study we propose a multistage mathematical model of coopetitive games to show how the adoption of a coopetitive framework, which considers cooperation and competition simultaneously, may advance our understanding of the study of asymmetric research and developemnt (R&D) alliances. Those alliances are aimed at exploring and/or exploiting knowledge between young and small firms and large multinational enterprises (MNEs). We selected this model, which is particularly suitable for exploring complex types of asymmetric R&D alliances that epitomize the biopharmaceutical industry, based upon the literature on asymmetric R&D cooperation and coopetition. In particular, we propose a formal coopetitive approach, where coopetition is a vector variable belonging to an n-dimensional Euclidean space. We graphically show that cooperative efforts are required and beneficial even though partners are potentially competitors in the marketplace and shape the common payoff space that they commonly create. By doing so, we highlight the requirement that coopetitive partners should balance effectively their interaction dynamics, interactions that affect both the value creation and value capture processes.
- 6 February 2016
- Published by Taylor & Francis in International Studies of Management & Organization
- Vol. 46 (2-3) , 179-201
Asymmetric R&D Alliances in the Biopharmaceutical Industry
In this study we propose a multistage mathematical model of coopetitive games to show how the adoption of a coopetitive framework, which considers cooperation and competition simultaneously, may advance our understanding of the study of asymmetric research and developemnt (R&D) alliances. Those alliances are aimed at exploring and/or exploiting knowledge between young and small firms and large multinational enterprises (MNEs). We selected this model, which is particularly suitable for exploring complex types of asymmetric R&D alliances that epitomize the biopharmaceutical industry, based upon the literature on asymmetric R&D cooperation and coopetition. In particular, we propose a formal coopetitive approach, where coopetition is a vector variable belonging to an n-dimensional Euclidean space. We graphically show that cooperative efforts are required and beneficial even though partners are potentially competitors in the marketplace and shape the common payoff space that they commonly create. By doing so, we highlight the requirement that coopetitive partners should balance effectively their interaction dynamics, interactions that affect both the value creation and value capture processes.
- 6 September 2013
- Published by Taylor & Francis in Technology Analysis & Strategic Management
- Vol. 25 (8) , 971-986
Capturing the real value of patent analysis for R&D strategies
Patent information can be used for strategic planning purposes. Conventional patent analysis has commonly focused on factual information and, in particular, on information extraction, visualisation and interpretation. Less scholarly attention has been devoted to the strategic role of an integrated system of patent intelligence in supporting decision-making in R&D investments. Our paper addresses this gap and explores how patent analysis may benefit those firms that intend capturing the beneficial effects of Open Innovation. We also critically discuss the intrinsic limits of both patent information and patent analysis, which should be taken into account by systems of patent intelligence.
- 6 September 2013
- Published by Taylor & Francis in Technology Analysis & Strategic Management
- Vol. 25 (8) , 971-986
Capturing the real value of patent analysis for R&D strategies
Patent information can be used for strategic planning purposes. Conventional patent analysis has commonly focused on factual information and, in particular, on information extraction, visualisation and interpretation. Less scholarly attention has been devoted to the strategic role of an integrated system of patent intelligence in supporting decision-making in R&D investments. Our paper addresses this gap and explores how patent analysis may benefit those firms that intend capturing the beneficial effects of Open Innovation. We also critically discuss the intrinsic limits of both patent information and patent analysis, which should be taken into account by systems of patent intelligence.
- 6 November 2012
- Published by Springer Nature in The Journal of Technology Transfer
- Vol. 39 (1) , 52-74
Closing the distance between academia and market: experimentation and user entrepreneurial processes
- 6 November 2012
- Published by Springer Nature in The Journal of Technology Transfer
- Vol. 39 (1) , 52-74
Closing the distance between academia and market: experimentation and user entrepreneurial processes
- 1 July 2012
- Published by Academy of Management in Academy of Management Proceedings
- Vol. 2012 (1)
The How and Who of IP-Based New Product Development:The Case of STMicroelectronics’ Lab-on-Chip
This paper addresses the question of how patent-related information can be used by firms to support new product development decisions and, in general, to design R&D strategies. While the importance of patent analysis in strategic planning has become increasingly evident, less scholarly attention has been devoted to the effort to integrate a range of patent information to support decision-making in R&D. We propose an integrated conceptual framework to understand which tasks and techniques are more helpful both to enhance the supporting role of patent analysis to R&D strategy formulation, and to make the connection between the technological domain and the market domain effective. The discussion is complemented by a case study analysis, which concerns the launch of an original biotechnological product (Lab-on-Chip – a disposable device that integrates all the functions needed to perform a DNA test on a blood sample) by the semiconductors’ manufacturer STMictroelectronics. The case represents an emblematic example of how patent information has been effectively applied to support new product development decisions. We also show how the effective implementation of such analytical process required an organizational adaptation to the firm aimed at easing the integration of IP-office and R&D department. In turn, we discuss the strategic, managerial and organizational implications arising from the results of the STMictroelectronics case.
- 1 July 2012
- Published by Academy of Management in Academy of Management Proceedings
- Vol. 2012 (1)
The How and Who of IP-Based New Product Development:The Case of STMicroelectronics’ Lab-on-Chip
This paper addresses the question of how patent-related information can be used by firms to support new product development decisions and, in general, to design R&D strategies. While the importance of patent analysis in strategic planning has become increasingly evident, less scholarly attention has been devoted to the effort to integrate a range of patent information to support decision-making in R&D. We propose an integrated conceptual framework to understand which tasks and techniques are more helpful both to enhance the supporting role of patent analysis to R&D strategy formulation, and to make the connection between the technological domain and the market domain effective. The discussion is complemented by a case study analysis, which concerns the launch of an original biotechnological product (Lab-on-Chip – a disposable device that integrates all the functions needed to perform a DNA test on a blood sample) by the semiconductors’ manufacturer STMictroelectronics. The case represents an emblematic example of how patent information has been effectively applied to support new product development decisions. We also show how the effective implementation of such analytical process required an organizational adaptation to the firm aimed at easing the integration of IP-office and R&D department. In turn, we discuss the strategic, managerial and organizational implications arising from the results of the STMictroelectronics case.
- 1 January 2008
- Published by Springer Nature in MRS Proceedings
- Vol. 1106
Exploiting Nanotech Opportunities: A Strategic Entrepreneurship Perspective
- 1 January 2008
- Published by Springer Nature in MRS Proceedings
- Vol. 1106
Exploiting Nanotech Opportunities: A Strategic Entrepreneurship Perspective